A growing body of scientific evidence suggests a positive relationship between microdosing psychedelic drugs and an improvement of mental disorders such as depression. We explore which drugs are commonly used for microdosing, how they work and the potential benefits and challenges they present.

Chronic pain needs a comprehensive approach, considering biological, psychological, and social factors. Emerging technologies like VR, gene therapy, and stem cell interventions show promise. Personalized care and early intervention can improve outcomes and reduce costs. Collaboration among stakeholders is essential to mitigate chronic pain’s impact.

PSA screening for prostate cancer presents key considerations for insurers. While it aids early detection, concerns about overdiagnosis highlight the need for careful evaluation. Insurers must balance screening requirements with ethical implications, ensuring tests are conducted appropriately.

Approximately one billion people across the globe are estimated to have Obstructive Sleep Apnea, making it the most common respiratory-related sleep disorder. Learn more about this medical condition including risk factors, how it’s diagnosed, complications, treatments and future therapies.